Deep brain stimulation of the subthalamic nucleus transiently enhances loss-chasing behaviour in patients with Parkinson's Disease

Experimental Neurology

Volumn 231, Issue 1, 2011, Pages 181-189

  Rogers, Robert D ^a   Wielenberg, Birgit ^b   Wojtecki, Lars ^b   Elben, Saskia ^b   Campbell Meiklejohn, Daniel ^a   Schnitzler, Alfons ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Deep brain stimulation; Parkinson's Disease; Pathological gambling; Reward; Subthalamic nucleus

Indexed keywords

AMANTADINE; AMITRIPTYLINE; CABERGOLINE; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; ENTACAPONE; ESCITALOPRAM; LEVODOPA; MIRTAZAPINE; PRAMIPEXOLE; QUETIAPINE; RIVASTIGMINE; ROPINIROLE; ROTIGOTINE; SULPIRIDE; TETRAZEPAM; TOLCAPONE; VENLAFAXINE; ZOPICLONE;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; ELECTRODE; ELECTROSTIMULATION THERAPY; EXPLORATORY RESEARCH; FEMALE; HUMAN; IDIOPATHIC DISEASE; MAJOR DEPRESSION; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; SEX DIFFERENCE; SUBTHALAMIC NUCLEUS; THERAPY EFFECT; VERTIGO;

ADULT; AGED; BASAL GANGLIA; DEEP BRAIN STIMULATION; DOPAMINE; DOPAMINE AGONISTS; FEMALE; GAMBLING; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; PARKINSON DISEASE; REWARD; SEX CHARACTERISTICS; SUBTHALAMIC NUCLEUS;

EID: 79961025852     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.06.007     Document Type: Article

References (68)

1. Alegret M., Valldeoriola F., Marti M., Pilleri M., Junque C., Rumia J., et al. Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease. Mov. Disord. 2004, 19(12):1463-1469. (Dec).
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision) 2000, American Psychiatric Publishing, Inc., Washington, DC.
3. Ardouin C., Voon V., Worbe Y., Abouazar N., Czernecki V., Hosseini H., et al. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov. Disord. 2006, 21(11):1941-1946. (Nov).
4. Aron A.R., Behrens T.E., Smith S., Frank M.J., Poldrack R.A. Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (MRI) and functional MRI. J. Neurosci. 2007, 27:3743-3752.
5. Ballanger B., van Eimeren T., Moro E., Lozano A.M., Hamani C., Boulinguez P., et al. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann. Neurol. 2009, 66(6):817-824. (Dec).
6. Bandini F., Primavera A., Pizzorno M., Cocito L. Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13(6):369-371. (Aug).
7. Beck A.T., Ward C.H., Medelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
8. Campbell M.C., Karimi M., Weaver P.M., Wu J., Perantie D.C., Golchin N.A., et al. Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia 2008, 46(13):3162-3169. (Nov).
9. Campbell-Meiklejohn D.K., Woolrich M.W., Passingham R.E., Rogers R.D. Knowing when to stop: the brain mechanisms of chasing losses. Biol. Psychiatry 2008, 63(3):293-300. (Feb 1).
10. Campbell-Meiklejohn D., Wakeley J., Herbert V., Cook J., Scollo P., Kar Ray M., Selvaraj S., Passingham R.E., Cowen P.J., Rogers R.D. Serotonin and dopamine play complementary roles in gambling to recover losses: Implications for pathological gambling. Neuropsychopharmacology 2010, 36:402-410.
11. Carter C.S., Macdonald A.M., Botvinick M., Ross L.L., Stenger V.A., Noll D., et al. Parsing executive processes: strategic vs. evaluative functions of the anterior cingulate cortex. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(4):1944-1948. (Feb 15).
12. Chudasama Y., Baunez C., Robbins T.W. Functional disconnection of the medial prefrontal cortex and subthalamic nucleus in attentional performance: evidence for corticosubthalamic interaction. J. Neurosci. 2003, 23(13):5477-5485. (Jul 2).
13. Corless T., Dickerson M. Gamblers' self-perceptions of the determinants of impaired control. Br. J. Addict. 1989, 84(12):1527-1537. (Dec).
14. Creigh-Tyte S., Lepper J. Gender Differences in Participation in, and Attitudes towards, Gambling in the UK: Results from the 2004 NOP Survey 2004.
15. Cubitt R., Starmer C., Sugden R. On the validity of the random lottery incentive system. Exp. Econ. 1998, 1:115-131.
16. Dagher A., Robbins T.W. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 2009, 61(4):502-510. (Feb 26).
17. Dickerson M., Hinchy J., Fabre J. Chasing, arousal and sensation seeking in off-course gamblers. Br. J. Addict. 1987, 82(6):673-680. (Jun).
18. Driver-Dunckley E., Samanta J., Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003, 61(3):422-423. (Aug 12).
19. Evans A.H., Katzenschlager R., Paviour D., O'Sullivan J.D., Appel S., Lawrence A.D., et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov. Disord. 2004, 19(4):397-405. (Apr).
20. Fahn S., Elton R. UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. Recent Developments in Parkinson's Disease 1987, 153-163. Macmillan, Florham Park, NJ. S. Fahn, C. Marsden, D. Calne, M. Goldstein (Eds.).
21. Ferrara J.M., Stacy M. Impulse-control disorders in Parkinson's disease. CNS Spectr. 2008, 13(8):690-698. (August).
22. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis-I Disorders, Research Version, Patient Edition 2002, (SCID-I/P)., Biometrics Research, New York.
23. Frank M.J. Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making. Neural Netw. 2006, 19(8):1120-1136. (Oct).
24. Frank M.J., Claus E.D. Anatomy of a decision: striato-orbitofrontal interactions in reinforcement learning, decision making, and reversal. Psychol. Rev. 2006, 113(2):300-326. (Apr).
25. Frank M.J., Samanta J., Moustafa A.A., Sherman S.J. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007, 318(5854):1309-1312. (Nov 23).
26. Frank M.J., Scheres A., Sherman S.J. Understanding decision-making deficits in neurological conditions: insights from models of natural action selection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007, 362(1485):1641-1654. (Sep 29).
27. Hautzinger M., Bailer M., Worral H., Keller F. Das Beck Depressions-Inventar (BDI) 1995, Huber, Bern.
28. Heo J.H., Lee K.M., Paek S.H., Kim M.J., Lee J.Y., Kim J.Y., et al. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease. J. Neurol. Sci. 2008, 273(1-2):19-24. (Oct 15).
29. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17(5):427-442. (May).
30. Jahanshahi M., Ardouin C.M., Brown R.G., Rothwell J.C., Obeso J., Albanese A., et al. The impact of deep brain stimulation on executive function in Parkinson's disease. Brain 2000, 123(Pt 6):1142-1154. (Jun).
31. Kahneman D., Tversky A. Prospect theory: an analysis of decisions under risk. Econometrica 1979, 47:263-291.
32. Kahneman D., Tversky A. Choices Values and Frames 2000, Cambridge University Press, Cambridge, UK.
33. Kalbe E., Voges J., Weber T., Haarer M., Baudrexel S., Klein J.C., et al. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology 2009, 72(1):42-49. (Jan 6).
34. Klempirova O., Jech R., Urgosik D., Klempir J., Spackova N., Roth J., et al. Deep brain stimulation of the subthalamic nucleus and cognitive functions in Parkinson's disease. Prague Med. Rep. 2007, 108(4):315-323.
35. Krack P., Batir A., Van Blercom N., Chabardes S., Fraix V., Ardouin C., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 2003, 349(20):1925-1934. (Nov 13).
36. Lawrence A.J., Blackwell A.D., Barker R.A., Spagnolo F., Clark L., Aitken M.R., et al. Predictors of punding in Parkinson's disease: results from a questionnaire survey. Mov. Disord. 2007, 22(16):2339-2345. (Dec).
37. Lesieur H. The Chase: Career of the Compulsive Gambler 1977, Anchor Press/Doubleday, Garden City, New York. First ed.
38. Lesieur H.R. The compulsive gambler's spiral of options and involvement. Psychiatry 1979, 42(1):79-87. (Feb).
39. Lesieur H.R., Blume S.B. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am. J. Psychiatry 1987, 144(9):1184-1188. (Sep).
40. Levy R., Hazrati L.N., Herrero M.T., Vila M., Hassani O.K., Mouroux M., et al. Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience 1997, 76(2):335-343. (Jan).
41. Lim S.Y., O'Sullivan S.S., Kotschet K., Gallagher D.A., Lacey C., Lawrence A.D., et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J. Clin. Neurosci. 2009, 16(9):1148-1152. (Sep).
42. Nakano K., Kayahara T., Tsutsumi T., Ushiro H. Neural circuits and functional organization of the striatum. J. Neurol. 2000, 247(Suppl. 5):V1-V15. (Sep).
43. Okun M.S., Green J.R., Saben R., Gross R., Foote K.D., Vitek J.L. Mood changes with deep brain stimulation of STN and GPi: results of a pilot study. J. Neurol. Neurosurg. Psychiatry 2003, 74:1584-1586.
44. Pillon B., Ardouin C., Damier P., Krack P., Houeto J.L., Klinger H., et al. Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology 2000, 55(3):411-418. (Aug 8).
45. Rosen A.B., Tsai J.S., Downs S.M. Variations in risk attitude across race, gender, and education. Med. Decis. Making 2003, 23(6):511-517. (Nov-Dec).
46. Rushworth M.F., Walton M.E., Kennerley S.W., Bannerman D.M. Action sets and decisions in the medial frontal cortex. Trends Cogn. Sci. 2004, 8(9):410-417. (Sep).
47. Saint-Cyr J.A., Trepanier L.L., Kumar R., Lozano A.M., Lang A.E. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000, 123(Pt 10):2091-2108. (Oct).
48. Schmidt R., Freidl W., Fazekas F., Reinhart B., Grieshofer P., Koch M., et al. The Mattis Dementia Rating Scale: normative data from 1,001 healthy volunteers. Neurology 1994, 44(5):964-966. (May).
49. Schöttle D., Rode S., Krüger S., Bräunig P. Selbstbeurteilungsskalen für manische Episoden. Psychiatr. Prax. 2006, 33(Supplementary 1).
50. Shafir E., Tversky A. Decision making. Thinking 1995, 77-100. MIT Press, Cambridge, MA. E.E. Smith, D.N. Oscherson (Eds.).
51. Shugar G., Schertzer S., Toner B.B., Di Gasbarro I. Development, use, and factor analysis of a self-report inventory for mania. Compr. Psychiatry 1992, 33(5):325-331.
52. Smeding H.M., Goudriaan A.E., Foncke E.M., Schuurman P.R., Speelman J.D., Schmand B. Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J. Neurol. Neurosurg. Psychiatry 2007, 78(5):517-519. (May).
53. Stefurak T., Mikulis D., Mayberg H., Lang A.E., Hevenor S., Pahapill P., et al. Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study. Mov. Disord. 2003, 18(12):1508-1516. (Dec).
54. Swainson R., Rogers R.D., Sahakian B.J., Summers B.A., Polkey C.E., Robbins T.W. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 2000, 38(5):596-612.
55. Swann N., Poizner H., Houser M., Gould S., Greenhouse I., Cai W., Strunk J., George J., Aron A.R. Deep brain stimulation of the subthalamic nucleus alters the cortical profile of response inhibition in the Beta frequency band: a scalp EEG study in Parkinson's disease. J. Neurosci. 2011, 31:5721-5729.
56. Takada M., Tokuno H., Hamada I., Inase M., Ito Y., Imanishi M., et al. Organization of inputs from cingulate motor areas to basal ganglia in macaque monkey. Eur. J. Neurosci. 2001, 14(10):1633-1650. (Nov).
57. Tversky A., Kahneman D. The framing of decisions and the psychology of choice. Science 1981, 211(4481):453-458. (Jan 30).
58. Tversky A., Kahneman D. Advances in prospect theory: cumulative representation of uncertainty. J. Risk Uncertainty 1992, 5(4):297-323.
59. van Eimeren T., Ballanger B., Pellecchia G., Miyasaki J.M., Lang A.E., Strafella A.P. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?. Neuropsychopharmacology 2009, 34(13):2758-2766. (Dec).
60. Voon V., Hassan K., Zurowski M., Duff-Canning S., de Souza M., Fox S., et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 2006, 66(11):1750-1752. (Jun 13).
61. Voon V., Krack P., Lang A.E., Lozano A.M., Dujardin K., Schüpbach M., D'Ambrosia J., et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008, 131:2720-2728.
62. Voon V., Thomsen T., Miyasaki J.M., de Souza M., Shafro A., Fox S.H., et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch. Neurol. 2007, 64(2):212-216. (Feb).
63. Voon V., Pessiglione M., Brezing C., Gallea C., Fernandez H.H., Dolan R.J., et al. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010, 65:135-142.
64. Watson D., Clark L.A., Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 1988, 54(6):1063-1070. (Jun).
65. Weintraub D., Siderowf A.D., Potenza M.N., Goveas J., Morales K.H., Duda J.E., et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch. Neurol. 2006, 63(7):969-973. (Jul).
66. Winstanley C.A., Baunez C., Theobald D.E., Robbins T.W. Lesions to the subthalamic nucleus decrease impulsive choice but impair autoshaping in rats: the importance of the basal ganglia in Pavlovian conditioning and impulse control. Eur. J. Neurosci. 2005, 21(11):3107-3116. (Jun).
67. Witjas T., Baunez C., Henry J.M., Delfini M., Regis J., Cherif A.A., et al. Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation. Mov. Disord. 2005, 20(8):1052-1055. (Aug).
68. Witt K., Daniels C., Reiff J., Krack P., Volkmann J., Pinsker M.O., Krause M., Tronnier V., Kloss M., Schnitzler A., Wojtecki L., Bötzel K., Danek A., Hilker R., Sturm V., Kupsch A., Karner E., Deuschl G. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol. 2008, 7(7):605-614.